Advertisement
Screener

Allogene Therapeutics, Inc. (ALLO) ROA

Allogene Therapeutics, Inc. (ALLO) ROA

  • 2026-06-30: ROA -30.08%.
  • 2026-03-31: ROA -43.88%.
  • 2025-12-31: ROA -45.90%.
  • 2025-09-30: ROA -48.21%.

Complete source-backed roa history.

Available history
2018-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-30.08%
2026-03-31-43.88%
2025-12-31-45.90%
2025-09-30-48.21%
2025-06-30-50.34%
2025-03-31-49.67%
2024-12-31-46.94%
2024-09-30-48.11%
2024-06-30-43.20%
2024-03-31-49.85%
2023-12-31-50.91%
2023-09-30-47.48%
2023-06-30-46.52%
2023-03-31-47.35%
2022-12-31-40.78%
2022-09-30-26.57%
2022-06-30-24.35%
2022-03-31-23.40%
2021-12-31-17.53%
2021-09-30-23.23%
2021-06-30-21.19%
2021-03-31-19.40%
2020-12-31-20.38%
2020-09-30-19.85%
2020-06-30-18.05%
2020-03-31-30.14%
2019-12-31-25.72%
2019-09-30-22.15%
2019-06-30-20.00%
2019-03-31-32.09%
2018-12-31-27.33%

Annual ROA

DateROA
2025-12-31-45.90%
2024-12-31-46.94%
2023-12-31-50.91%
2022-12-31-41.43%
2021-12-31-17.53%
2020-12-31-20.38%
2019-12-31-25.72%
2018-12-31-27.33%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Prime Medicine, Inc. (PRME)United States$0.557B-3.54
Aura Biosciences, Inc. (AURA)United States$0.639B-5.61
Autolus Therapeutics plc (AUTL)$0.506B-1.52
Entera Bio Ltd. (ENTX)$0.485B
REGENXBIO Inc. (RGNX)United States$0.477B-3.30
Tectonic Therapeutic, Inc. (TECX)United States$0.469B-7.68
Eikon Therapeutics, Inc. (EIKN)United States$0.446B
Kyverna Therapeutics, Inc. (KYTX)United States$0.434B-3.60
Editas Medicine, Inc. (EDIT)United States$0.424B-4.29
4D Molecular Therapeutics, Inc. (FDMT)United States$0.733B-4.10